Dr Reddys Laboratories (RDY) FCF Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) FCF Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 427.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 410.00 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2,205.00 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | -1,494.00 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 1,328.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -5,838.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1,382.00 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 889.00 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,205.00 |
| Sep 30, 2025 | 260.00 |
| Jun 30, 2025 | 742.00 |
| Sep 30, 2024 | -1,039.00 |
| Jun 30, 2024 | -415.00 |
| Mar 31, 2024 | -972.00 |
| Dec 31, 2023 | -2,970.00 |
| Sep 30, 2023 | 1,346.00 |
| Jun 30, 2023 | 279.00 |
| Mar 31, 2023 | 974.00 |
| Dec 31, 2022 | 162.00 |
| Sep 30, 2022 | 122.00 |
| Jun 30, 2022 | 1,953.00 |
| Mar 31, 2022 | -560.00 |
| Dec 31, 2021 | 2,501.00 |
| Sep 30, 2021 | -669.00 |
| Jun 30, 2021 | -2,476.00 |
| Mar 31, 2021 | 1,997.00 |
| Dec 31, 2020 | -550.00 |
| Sep 30, 2020 | -390.00 |